Trastuzumab Completed Phase 4 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02445586Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
NCT00127933XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
NCT01301729A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment